glp-1 drugs heart failure Glucagon-Like Peptide-1 Agonist Use in Adults With Congenital Disease: Effect, Safety, and Outcomes GLP-1s Reduced Adverse Heart Failure

Increased risk of atrial fibrillation and stroke during active stages of inflammatory bowel disease: a nationwide study

Here, we sought to test these hypotheses by recruiting a cohort with obesity 19 either taking GLP-1 RAs or not and test breath alcohol content (BrAc) and subjective feelings after an alcohol challenge dose

99 Until more robust trials confirm their safety specifically in patients with reduced LVEF, GLP-1 RAs should be used cautiously in this population

Individuals who smoked cigarettes showed significantly greater reductions in cigarettes per day when receiving semaglutide compared to the placebo group 22